Latest in 4.50 Mizuho
Sort by
5 items
-
-
-
-
-
This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho
Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...Business - MarketWatch - 13 hours ago